Barriers to preventive intervention

Gastroenterology Clinics of North America

Volumn 31, Issue 4, 2002, Pages 1061-1068

  Petersen, Gloria M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CONTROL; CANCER SCREENING; COLORECTAL CANCER; COLORECTAL DISEASE; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; OUTCOMES RESEARCH; PATIENT ATTITUDE; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; REVIEW;

ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; COLORECTAL NEOPLASMS; CULTURAL CHARACTERISTICS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HUMANS; SOCIOECONOMIC FACTORS;

EID: 0036895883     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(02)00052-3     Document Type: Review

References (48)

1. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: Update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Cancer J Clin 2001;51:38-75.
2. U.S. Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. 2nd Edition. Washington, DC: U.S. Government Printing Office; 2000.
3. Division of Adult and Community Health. National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Online Prevalence Data, 1995-2000. http://apps.nccd.cdc.gov/brfss/index.asp. Accessed October 15, 2002.
4. Vernon SW. Participation in colorectal cancer screening: A review. J Natl Cancer Inst 1997;89:1406-22.
5. Myers RE, Ross EA, Wolf TA, et al. Behavioral intentions to increase adherence in colorectal cancer screening. Med Care 1991;29:1039-50.
6. Struewing JP, Pape DM, Snow DA. Improving colorectal cancer screening in a medical residents' primary care clinic. Am J Prev Med 1991;7:75-81.
7. Thompson RS, Michnich ME, Gray J, et al. Maximizing compliance with hemoccult screening for colon cancer in clinical practice. Med Care 1986;24:904-14.
8. Faivre J, Arveux P, Milan C, et al. Participation in mass screening for colorectal cancer: Results of screening and rescreening from the Burgundy Study. Eur J Cancer Prev 1991;1:49-55.
9. Klaaborg K, Madsen MS, Sondergaard O, et al. Participation in mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol 1987;22:667-86.
10. Schroy PC III, Wilson S, Afdhal N. Feasibility of high-volume screening sigmoidoscopy using a flexible fiberoptic endoscope and a disposable sheath system. Am J Gastroenterol 1996;91:1331-7.
11. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood test. Lancet 1996;348:1472-7.
12. Jansen JH. Participation in the first and second round of a mass-screening for colorectal cancer. Soc Sci Med 1984;18:633-6.
13. Myers RE, Trock BJ, Lerman C, et al. Adherence to colorectal cancer screening in an HMO population. Prev Med 1990;19:502-14.
14. Bat L, Pines A, Ron E, et al. A community-based program of colorectal screening in an asymptomatic population: Evaluation of screening tests and compliance. Am J Gastroenterol 1986;81:647-51.
15. Codori AM, Petersen GM, Miglioretti DL, et al. Health beliefs and endoscopic screening for colorectal cancer: Potential for cancer prevention. Prev Med 2001;33:128-36.
16. Frew E, Wolstenholme J, Whynes D. Mass population screening for colorectal cancer: Factors influencing subjects' choice of screening test. J Health Serv Res Policy 2001;6:85-91.
17. Hoogewerf PE, Hislop TG, Morrison BJ, et al. Patient compliance with screening for fecal occult blood in family practice. Canad Med Assoc J 1987;137:195-8.
18. Macrae FA, St John DJ, Ambikapathy A, et al. Factors affecting compliance in colorectal cancer screening. Results of a study performed in Ballarat. Med J Austral 1986;144:621-3.
19. McCarthy BD, Moskowitz MA. Screening flexible sigmoidoscopy: Patient attitudes and compliance. J Gen Intern Med 1993;8:120-5.
20. Ore L, Hagoel L, Lavi I, et al. Screening with faecal occult blood test (FOBT) for colorectal cancer: Assessment of two methods that attempt to improve compliance. Eur J Cancer Prev 2001;10:251-6.
21. Sutton S, Wardle J, Taylor T, et al. Predictors of attendance in the United Kingdom flexible sigmoidoscopy screening trial. J Med Screen 2000;7:99-104.
22. Thomas W, White CM, Mah J, et al. Longitudinal compliance with annual screening for fecal occult blood. Minnesota Colon Cancer Control Study. Am J Epidemiol 1995;142:176-82.
23. Clavel-Chapelon F, Joseph R, Goulard H. Surveillance behavior of women with a reported family history of colorectal cancer. Prev Med 1999;28:174-8.
24. Harris MA, Byles JE. A survey of screening compliance among first degree relatives of people with colon cancer in New South Wales. J Med Screen 1997;4:29-34.
25. Lewis SF, Jensen NM. Screening sigmoidoscopy. Factors associated with utilization. J Gen Intern Med 1996;11:542-4.
26. Richardson JL, Danley K, Mondrus GT, et al. Adherence to screening examinations for colorectal cancer after diagnosis in a first-degree relative. Prev Med 1995;24:166-70.
27. Shapiro JA, Seeff LC, Nadel MR. Colorectal cancer-screening tests and associated health behaviors. Am J Prev Med 2001;21:132-7.
28. Powe BD. Fatalism among elderly African Americans. Effects on colorectal cancer screening. Cancer Nurs 1995;18:385-92.
29. Wardle J, Sutton S, Williamson S, et al. Psychosocial influences on older adults' interest in participating in bowel cancer screening. Prev Med 2000;31:323-34.
30. Weitzman ER, Zapka J, Estabrook B, et al. Risk and reluctance: Understanding impediments to colorectal cancer screening. Prev Med 2001;32:502-13.
31. Li T, Nakama H, Wei N. Reasons for non-compliance in colorectal cancer screening with fecal occult blood test. Eur J Med Res 1998;3:397-400.
32. Paskett ED, Rushing J, D'Agostino R Jr, et al. Cancer screening behaviors of low-income women: The impact of race. Womens Health 1997;3:203-26.
33. Beeker C, Kraft JM, Southwell BG, et al. Colorectal cancer screening in older men and women: Qualitative research findings and implications for intervention. J Community Health 2000;25:263-78.
34. DiPalma AM, Barnes SE, DiPalma JA. Patient participation in colon cancer screening programs. South Med J 1998;91:342-4.
35. Hart AR, Barone TL, Mayberry JF. Increasing compliance with colorectal cancer screening: The development of effective health education. Health Educ Res 1997;12:171-80.
36. Hynam KA, Hart AR, Gay SP, et al. Screening for colorectal cancer: Reasons for refusal of faecal occult blood testing in a general practice in England. J Epidemiol Commun Health 1995;49:84-6.
37. Bolen JC, Rhodes L, Powell-Griner EE, et al. State-specific prevalence of selected health behaviors, by race and ethnicity-Behavioral Risk Factor Surveillance System, 1997. MMWR. CDC Surveillance Summaries 2000;49:1-60.
38. Glaser SR. Utilization of sigmoidoscopy by family physicians in Canada. Can Med Assoc J 1994;150:367-71.
39. Knopf KB, Warren JL, Feuer EJ, et al. Bowel surveillance patterns after a diagnosis of colorectal cancer in Medicare beneficiaries. Gastrointest Endosc 2001;54:563-71.
40. Cooper GS, Fortinsky RH, Hapke R, et al. Factors associated with the use of flexible sigmoidoscopy as a screening test for the detection of colorectal carcinoma by primary care physicians. Cancer 1998;82:1476-81.
41. Cornuz J, Ghali WA, Di Carlantonio D, et al. Physicians' attitudes towards prevention: Importance of intervention-specific barriers and physicians' health habits. Fam Pract 2000; 17:535-40.
42. Dietrich AJ, Barrett J, Levy D, et al. Impact of an educational program on physician cancer control knowledge and activities. Am J Prev Med 1990;6:346-52.
43. Friedman LC, Webb JA, Richards CS, et al. Psychological and behavioral factors associated with colorectal cancer screening among Ashkenazim. Prev Med 1999;29:119-25.
44. James AS, Campbell MK, Hudson MA. Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: How does perception relate to screening behavior? Cancer Epidemiol Biomarkers Prev 2002;11:529-34.
45. Kelly RB, Shank JC. Adherence to screening flexible sigmoidoscopy in asymptomatic patients. Med Care 1992;30:1029-42.
46. Tong S, Hughes K, Oldenburg B, et al. Socio-demographic correlates of screening intention for colorectal cancer. Austral New Zealand J Pub Health 2000;24:610-4.
47. Frew E, Wolstenholme JL, Atkin W, et al. Estimating time and travel costs incurred in clinic based screening: Flexible sigmoidoscopy screening for colorectal cancer. J Med Screen 1999;6:119-23.
48. Neale AV, Demers RY, Herman S. Compliance with colorectal cancer screening in a high-risk occupational group. J Occup Med 1989;31:1007-12.